自身炎症性疾病的诊疗进展
Advances in the Diagnosis and Treatment of Autoinflammatory Diseases
摘要: 自身炎症性疾病(autoinflammatory dieases, AIDs)是由于固有免疫系统缺陷或功能紊乱,进而引起全身炎症反应的一组疾病。它多以复发性全身炎症反应和多系统受累为特征,临床上可表现为周期性的发热、皮疹或关节炎等多种形式。近年来,临床医师对该类疾病的认识不断加深,AIDs已成为一组涵盖范围广泛的疾病谱。目前广义的AIDs不仅包括50余种单基因疾病,还包含了一些尚未发现致病基因的多基因病,如全身型幼年特发性关节炎、白塞病、炎症性肠病等。而狭义的AIDs主要指基因突变引起固有免疫失调的单基因遗传病。本综述将着重阐述单基因AIDs的定义、发病机制、分类、临床表现、诊断和治疗。
Abstract: Autoinflammatory diseases (AIDs) are a group of diseases that cause systemic inflammatory re-sponses due to defects or dysfunction of the innate immune system. It is mostly characterized by recurrent systemic inflammatory response and multi-system involvement, and clinically it can be manifested in various forms such as periodic fever, rash or arthritis. In recent years, clinicians have deepened their understanding of such diseases, and AIDs have become a group of diseases covering a wide range of spectrum. At present, AIDs in a broad sense include not only more than 50 single gene diseases, but also some polygenic diseases for which no causative gene has been found, such as systemic juvenile idiopathic arthritis, Behcet’s disease, and inflammatory bowel disease. In the narrow sense, AIDs mainly refer to monogenic genetic diseases in which gene mutations cause in-nate immune disorders. This review will focus on the definition, pathogenesis, classification, clinical manifestations, diagnosis and treatment of monogenic AIDs.
文章引用:尹讯章. 自身炎症性疾病的诊疗进展[J]. 临床医学进展, 2023, 13(3): 4837-4844. https://doi.org/10.12677/ACM.2023.133691

参考文献

[1] Mcdermott, M.F., Aksentijevich, I., Galon, J., et al. (1999) Germline Mutations in the Extracellular Domains of the 55 kDa TNF Receptor, TNFR1, Define a Family of Dominantly Inherited Autoinflammatory Syndromes. Cell, 97, 133-144. [Google Scholar] [CrossRef
[2] Mcgonagle, D. and Mcdermott, M.F. (2006) A Proposed Classification of the Immunological Diseases. PLOS Medicine, 3, e297. [Google Scholar] [CrossRef] [PubMed]
[3] 高思豪, 宋红梅. 快速进展的自身炎症性疾病[J]. 罕见病研究, 2022, 1(3): 238-244.
[4] Ben-Chetrit, E., Gattorno, M., Gul, A., et al. (2018) Consensus Proposal for Taxonomy and Definition of the Autoinflammatory Diseases (AIDs): A Delphi Study. Annals of Rheumatic Diseases, 77, 1558-1565. [Google Scholar] [CrossRef] [PubMed]
[5] Martinon, F., Burns, K. and Tschopp, J. (2002) The In-flammasome: A Molecular Platform Triggering Activation of Inflammatory Caspases and Processing of proIL-beta. Mo-lecular Cell, 10, 417-426. [Google Scholar] [CrossRef
[6] Masters, S.L., Simon, A., Aksentijevich, I., et al. (2009) Horror Autoinflammaticus: The Molecular Pathophysiology of Autoinflammatory Disease. Annual Review of Immunolo-gy, 27, 621-668. [Google Scholar] [CrossRef] [PubMed]
[7] Martinez-Quiles, N. and Goldbach-Mansky, R. (2018) Updates on Autoinflammatory Diseases. Current Opinion in Immunology, 55, 97-105. [Google Scholar] [CrossRef] [PubMed]
[8] Havnaer, A. and Han, G. (2019) Autoinflammatory Disorders: A Review and Update on Pathogenesis and Treatment. American Journal of Clinical Dermatology, 20, 539-564. [Google Scholar] [CrossRef] [PubMed]
[9] Yang, C.A. and Chiang, B.L. (2021) Inflammasomes and Childhood Autoimmune Diseases: A Review of Current Knowledge. Clinical Reviews in Allergy & Immunology, 61, 156-170. [Google Scholar] [CrossRef] [PubMed]
[10] Tangye, S.G., Al-Herz, W., Bousfiha, A., et al. (2022) Human Inborn Errors of Immunity: 2022 Update on the Classification from the International Union of Immunological Societies Expert Committee. Journal of Clinical Immunology, 42, 1473-1507. [Google Scholar] [CrossRef] [PubMed]
[11] Tangye, S.G., Al-Herz, W., Bousfiha, A., et al. (2020) Human Inborn Errors of Immunity: 2019 Update on the Classification from the International Union of Immunological Societies Expert Committee. Journal of Clinical Immunology, 40, 24-64. [Google Scholar] [CrossRef] [PubMed]
[12] Sprenkeler, E.G.G., Webbers, S.D.S. and Kuijpers, T.W. (2021) When Actin Is Not Actin’ Like It Should: A New Category of Distinct Primary Immunodeficiency Disorders. Journal of Innate Immunity, 13, 3-25. [Google Scholar] [CrossRef] [PubMed]
[13] Steiner, A., Harapas, C.R., Masters, S.L., et al. (2018) An Update on Au-toinflammatory Diseases: Relopathies. Current Rheumatology Reports, 20, 39. [Google Scholar] [CrossRef] [PubMed]
[14] Di Donato, G., D’angelo, D.M., Breda, L., et al. (2021) Mono-genic Autoinflammatory Diseases: State of the Art and Future Perspectives. International Journal of Molecular Sciences, 22, 6360. [Google Scholar] [CrossRef] [PubMed]
[15] 中华医学会儿科学分会风湿病学组, 中国医师协会风湿免疫科医师分会儿科学组, 海峡两岸医药卫生交流协会风湿免疫病学专业委员会儿童学组, 等. 儿童自身炎症性疾病诊断与治疗专家共识[J]. 中华实用儿科临床杂志, 2022, 37(3): 161-172.
[16] Ter Haar, N.M., Oswald, M., Jeyaratnam, J., et al. (2015) Recommendations for the Management of Autoinflammatory Diseases. Annals of Rheumatic Diseases, 74, 1636-1644. [Google Scholar] [CrossRef] [PubMed]
[17] Demir, F., Gürler, E. and Sözeri, B. (2022) Efficacy of Anakinra Treatment in Pediatric Rheumatic Diseases: Our Single-Center Experience. Archives of Rheumatology, 37, 435-443. [Google Scholar] [CrossRef
[18] Li, W., Wang, W., Wang, W., et al. (2022) Janus Kinase Inhibitors in the Treatment of Type I Interferonopathies: A Case Series from a Single Center in China. Frontiers in Immunology, 13, Article ID: 825367. [Google Scholar] [CrossRef] [PubMed]
[19] Du, Y., Liu, M., Nigrovic, P.A., et al. (2023) Biologics and JAK Inhibitors for the Treatment of Monogenic Systemic Autoinflammatory Diseases in Children. Journal of Allergy and Clinical Immunology, 151, 607-618. [Google Scholar] [CrossRef] [PubMed]